Candidate Drug 80/5Technology Demonstration4 (Anti-dyslipidemic)

Accessibility Controls

Implementing Organization

CSIR-Institute of Minerals and Materials Technology (CSIR-IMMT), Bhubaneswar

Project Overview

Anti-Dyslipidemic drug especially used in Dyslipidemia of Diabetes, Metabolic syndrome Obesity For managing patients of hyperlipidemia especially triglycerides and cholesterol

Benefits

The compound inhibits the biosynthesis of cholesterol and reduces the rate of cholesterol turnover. It also stimulates the LDL receptor binding activity and thereby increasing the catabolism of LDL cholesterol and significantly reduces the lipid peroxidation. It has a Triglyceride lowering activity als which is the main Lipid abnormality found in Indian population.

Source

Source URL

www.cdri.res.in

Related Research

View All

Quick Information

Thrust Areas

Pharmaceutical Sciences

Focus Area

Hyperlipidemia Treatment

Output

TRL: Technology Readiness Level

Technology Demonstration

Accessibility Controls

All Technologies